Differences in patients with systemic sclerosis recruited from associations and tertiary care settings.
OBJECTIVE
To compare patients with systemic sclerosis (SSc) recruited from a patient association or a tertiary care setting.


METHODS
We evaluated 248 SSc patients attending 4 annual meetings of a patient association between 2004 and 2007 (177) or during hospitalization (71). health-related quality of life (HRQoL) was assessed by the SF-36, global disability by the health assessment questionnaire (HAQ), hand disability by the Cochin Hand Function Scale (CHFS), mouth disability by the Mouth Handicap in Systemic Sclerosis (MHISS) scale, global hand and wrist mobility by the Kapandji index.


RESULTS
As compared with hospitalized patients, those from the patient association were significantly older (mean age 58.73 ± 12.04 vs 53.818 ± 13.1; p=0.001) and had a longer disease duration (10.98 ± 8.7 vs 7.13 ± 6.723 p=0.0001). Association patients had significantly increased disability of the hand (CHFS 21.8 ± 19.8 vs 9.8 ± 14.1; p=0.0001) and mouth (MHISS 20.65 ± 10.8 vs 13.25 ± 9.3; p=0.0001) and impaired hand and wrist mobility (Kapandji score 38.05 ± 10.26 vs 43.90 ± 8.26, p=0.001). The 2 groups did not differ in global disability or physical and mental scores of the SF36.


CONCLUSIONS
Patients recruited from a patient association have more severe SSc than do hospitalized patients. This finding must be taken into account in the design of surveys and clinical trials.
Mestre-Stanislas
Caroline
C
Université Paris Descartes, Faculté de Médecine, Pôle de Médecine Interne, Centre de Référence pour les vascularites nécrosantes et la sclérodermie systémique, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.
Poiraudeau
Serge
S
Berezné
Alice
A
Rannou
François
F
Pagnoux
Christian
C
Revel
Michel
M
Guillevin
Loïc
L
Mouthon
Luc
L
D006233:Persons with Disabilities; D005260:Female; D006760:Hospitalization; D006801:Humans; D008297:Male; D008875:Middle Aged; D009938:Organizations; D011788:Quality of Life; D012595:Scleroderma, Systemic / Q000150:complications; D012720:Severity of Illness Index